Implementing a personalized medicine cancer program in a community cancer system

Lynn G Dressler; Gillian C Bell; David P Schuetze; Mark R Steciuk; Oliver A Binns; Rachel E Raab; Pearl M Abernathy; Carolyn M Wilson; Sedope E Kunutsor; Marika C Loveless; Paul M Ahearne; Michael J Messino

doi:10.2217/pme-2018-0112

Implementing a personalized medicine cancer program in a community cancer system

Per Med. 2019 May;16(3):221-232. doi: 10.2217/pme-2018-0112. Epub 2019 May 21.

Authors

Lynn G Dressler^{1

2

3

4}, Gillian C Bell⁴, David P Schuetze⁴, Mark R Steciuk⁴, Oliver A Binns⁴, Rachel E Raab^{4

5}, Pearl M Abernathy⁴, Carolyn M Wilson⁴, Sedope E Kunutsor^{4

6}, Marika C Loveless^{3

4}, Paul M Ahearne⁴, Michael J Messino⁴

Affiliations

¹ Independent Consultant, LGD consulting, Fairview, NC 287303, USA.
² Independent Consultant, Asheville, NC 288014, USA.
³ Duke University Research Institute, Durham, NC 28777, USA.
⁴ Mission Health Cancer Center, Hospital Drive, Asheville, NC 28801, USA.
⁵ Independent Scholar, Asheville, NC 2880, USA.
⁶ Texas Cancer Registry, Austin, TX 73301.

PMID: 31109249
DOI: 10.2217/pme-2018-0112

No abstract available

Keywords: Oncotype Dx; cancer genomics; cancer personalized medicine; community cancer practices; diffusion of innovation theory; dissemination science; implementation science; pharmacogenetics; somatic Lynch syndrome screening.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Community Networks / standards
Genomics
Humans
Neoplasms / genetics*
Pharmacogenetics
Practice Guidelines as Topic
Precision Medicine / methods*